<?xml version="1.0" encoding="UTF-8"?>
<ref id="B38-antioxidants-10-00875">
 <label>38.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Spyridopoulou</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Tryfonopoulou</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Aindelis</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Ypsilantis</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Sarafidis</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Kalogirou</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Chlichlia</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Biogenic selenium nanoparticles produced by 
   <italic>Lactobacillus casei</italic> ATCC 393 inhibit colon cancer cell growth in vitro and in vivo
  </article-title>
  <source>Nanoscale Adv.</source>
  <year>2021</year>
  <volume>3</volume>
  <fpage>2516</fpage>
  <lpage>2528</lpage>
  <pub-id pub-id-type="doi">10.1039/D0NA00984A</pub-id>
 </element-citation>
</ref>
